Telemetry Investments, L.L.C. Curis Inc Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.36 - $2.35 $35,648 - $61,598	-26,212 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.62 - $2.25 $3,720 - $13,500	-6,000 Reduced 18.63%	26,212 $18,000
Q3 2018 Nov 14, 2018	SELL	$1.38 - $1.94 $20,407 - $28,688	-14,788 Reduced 31.46%	32,212 $57,000
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $81,310 - $157,450	47,000 New	47,000 $81,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $332M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.